Oliviero James F III
CEO, President and Director at CKPT; Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC
- Sold, on record
- $15.1M
- Dollars the filings state
- Form 4 sales
- 44
- Latest Apr 2, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CKPTCheckpoint Therapeutics, Inc.CEO, President and Director
- KERYX BIOPHARMACEUTICALS INCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CKPT1.4M shares
- KERYX BIOPHARMACEUTICALS INC987,280 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CKPTPlan not statedFeb 1, 2023 2023
Sold 10,261 shares at $4.77 ($49k)
Oliviero James F III, CEO, President and Director
Sold 5.3% of holdings ($918k position)182,121 shares left0.1x usual sizeFiling
- 2 Form 4 sale CKPTPlan not statedMar 2, 2023 +29 days
Sold 11,031 shares at $4.82 ($53k)
Oliviero James F III, CEO, President and Director
Sold 7.1% of holdings ($748k position)144,090 shares left0.2x usual sizeFiling
- 3 Form 4 sale CKPTNo planFeb 1, 2024 +336 days
Sold 11,900 shares at $2.01 ($24k)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 3.1% of holdings ($767k position)369,680 shares left1.1x usual sizeFiling
- 4 Form 4 sale CKPTNo planFeb 28, 2024 +27 days
Sold 5,894 shares at $2.06 ($12k)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 1.7% of holdings ($735k position)350,836 shares left0.5x usual sizeFiling
- 5 Form 4 sale CKPTNo planJun 26, 2024 +119 days
Sold 24,610 shares at $2.05 ($50k)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 1.2% of holdings ($4.1M position)2M shares left2.4x usual sizeFiling
- 6 Form 4 sale CKPTUnusualDec 19, 2024 +176 days
Sold 822,397 shares at $3.74 ($3.1M)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 20.5% of holdings ($15M position)3.2M shares left77.2x usual sizeFiling
- 7 Form 4 sale CKPTNo planFeb 10, 2025 +53 days
Sold 19,564 shares at $3.27 ($64k)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 0.5% of holdings ($12.4M position)3.8M shares left1.6x usual sizeFiling
- 8 Form 4 sale CKPTNo planApr 2, 2025 +51 days
Sold 15,090 shares at $4.04 ($61k)
Oliviero James F III, CEO, President and Director
No 10b5-1 planSold 0.4% of holdings ($15.3M position)3.8M shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (44)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Apr 3, 2025 | CKPT | CEO, President and Director | Form 4 sale | 15,090 | $61k | 0.4% | No plan | SEC |
| Feb 10, 2025 | Feb 11, 2025 | CKPT | CEO, President and Director | Form 4 sale | 19,564 | $64k | 0.5% | No plan | SEC |
| Dec 19, 2024 | Dec 20, 2024 | CKPT | CEO, President and Director | Form 4 sale | 822,397 | $3.1M | 20.5% | Unusual | SEC |
| Jun 26, 2024 | Jun 28, 2024 | CKPT | CEO, President and Director | Form 4 sale | 24,610 | $50k | 1.2% | No plan | SEC |
| Feb 28, 2024 | Mar 1, 2024 | CKPT | CEO, President and Director | Form 4 sale | 5,894 | $12k | 1.7% | No plan | SEC |
| Feb 1, 2024 | Feb 2, 2024 | CKPT | CEO, President and Director | Form 4 sale | 11,900 | $24k | 3.1% | No plan | SEC |
| Mar 2, 2023 | Mar 3, 2023 | CKPT | CEO, President and Director | Form 4 sale | 11,031 | $53k | 7.1% | Plan not stated | SEC |
| Feb 1, 2023 | Feb 3, 2023 | CKPT | CEO, President and Director | Form 4 sale | 10,261 | $49k | 5.3% | Plan not stated | SEC |
| Jan 10, 2023 | Jan 12, 2023 | CKPT | CEO, President and Director | Form 4 sale | 3,817 | $26k | 1.9% | Plan not stated | SEC |
| Jun 23, 2022 | Jul 1, 2022 | CKPT | CEO, President and Director | Form 4 sale | 276,000 | $301k | 9.7% | Plan not stated | SEC |
| Apr 13, 2022 | Apr 22, 2022 | CKPT | CEO, President and Director | Form 4 sale | 121,641 | $212k | 4.1% | Plan not stated | SEC |
| Feb 5, 2021 | Feb 5, 2021 | CKPT | CEO, President and Director | Form 4 sale | 118,790 | $413k | 3.6% | Plan not stated | SEC |
| Jul 6, 2015 | Jul 8, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,943 | $19k | 0.9% | Plan not stated | SEC |
| Apr 6, 2015 | Apr 8, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,878 | $22k | 1.1% | Plan not stated | SEC |
| Jan 5, 2015 | Jan 6, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 5,604 | $77k | 3.2% | Plan not stated | SEC |
| Dec 10, 2014 | Dec 12, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 25,000 | $392k | 14.0% | Unusual | SEC |
| Oct 3, 2014 | Oct 7, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,694 | $43k | 1.7% | Plan not stated | SEC |
| Sep 8, 2014 | Sep 10, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 144,237 | $2.3M | 48.0% | Unusual | SEC |
| Jul 7, 2014 | Jul 9, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,054 | $32k | 0.7% | Plan not stated | SEC |
| Apr 3, 2014 | Apr 7, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,087 | $34k | 0.7% | Plan not stated | SEC |
| Mar 21, 2014 | Mar 21, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 292,483 | $4.4M | 49.0% | Unusual | SEC |
| Jan 3, 2014 | Jan 6, 2014 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 6,309 | $79k | 1.3% | Plan not stated | SEC |
| Dec 30, 2013 | Dec 31, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 109,500 | $1.4M | 18.7% | Unusual | SEC |
| Oct 3, 2013 | Oct 7, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,475 | $15k | 0.3% | Plan not stated | SEC |
| Jul 5, 2013 | Jul 9, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,438 | $11k | 0.3% | Plan not stated | SEC |
| May 13, 2013 | May 14, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 29,363 | $245k | 5.0% | Unusual | SEC |
| Apr 5, 2013 | Apr 8, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,484 | $10k | 0.3% | Plan not stated | SEC |
| Jan 4, 2013 | Jan 4, 2013 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 10,859 | $30k | 1.8% | Plan not stated | SEC |
| Oct 3, 2012 | Oct 5, 2012 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 4,973 | $14k | 0.9% | Plan not stated | SEC |
| Jul 3, 2012 | Jul 6, 2012 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 4,559 | $9k | 0.8% | Plan not stated | SEC |
| Apr 5, 2012 | Apr 5, 2012 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 5,458 | $9k | 3.0% | Plan not stated | SEC |
| Jan 3, 2012 | Jan 3, 2012 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 7,190 | $19k | 3.8% | Plan not stated | SEC |
| Oct 3, 2011 | Oct 5, 2011 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 6,105 | $17k | 3.6% | Plan not stated | SEC |
| Jul 5, 2011 | Jul 7, 2011 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 4,611 | $22k | 2.7% | Plan not stated | SEC |
| Jun 6, 2011 | Jun 8, 2011 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 47,231 | $236k | 21.6% | Unusual | SEC |
| Apr 5, 2011 | Apr 7, 2011 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 4,490 | $23k | 2.0% | Plan not stated | SEC |
| Jan 3, 2011 | Jan 3, 2011 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 14,064 | $66k | 5.9% | Plan not stated | SEC |
| Dec 6, 2010 | Dec 6, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 135,373 | $679k | 37.9% | Unusual | SEC |
| Oct 4, 2010 | Oct 6, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,209 | $6k | 0.3% | Plan not stated | SEC |
| Aug 20, 2010 | Aug 20, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 10,000 | $38k | 2.7% | Plan not stated | SEC |
| Jul 6, 2010 | Jul 8, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,213 | $4k | 0.3% | Plan not stated | SEC |
| Jun 8, 2010 | Jun 10, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 41,497 | $165k | 10.1% | Plan not stated | SEC |
| May 12, 2010 | May 14, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 60,000 | $376k | 12.7% | Plan not stated | SEC |
| Apr 5, 2010 | Apr 7, 2010 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 899 | $3k | 0.2% | Plan not stated | SEC |